Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: An observational study

Reproductive Sciences

Volumn 20, Issue 3, 2013, Pages 318-325

  Hofmann Kiefer, Klaus F ^a   Knabl, J ^b   Martinoff, N ^a   Schiessl, B ^b   Conzen, P ^a   Rehm, M ^a   Becker, B F ^a   Chappell, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

endothelial glycocalyx; HELLP syndrome; heparan sulfate; hyaluronic acid; syndecan 1

Indexed keywords

HEPARAN SULFATE; HYALURONIC ACID; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DELIVERY; FEMALE; GESTATIONAL AGE; GLYCOCALYX; HELLP SYNDROME; HUMAN; OBSERVATIONAL STUDY; PREGNANCY; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; FEMALE; GLYCOCALYX; HELLP SYNDROME; HUMANS; PREGNANCY;

EID: 84874463174     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112453508     Document Type: Article

References (60)

1. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007 ; 9: 121-167 (Pubitemid 350246654)
2. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000 ; 440 (5). 653-666
3. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007 ; 454 (3). 345-359 (Pubitemid 46742429)
4. Chappell D, Jacob M, Becker BF, Hofmann-Kiefer K, Conzen P, Rehm M.. Expedition glycocalyx. A newly discovered "Great Barrier Reef" [in German]. Anaesthesist. 2008 ; 57 (10). 959-969
5. Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992 ; 102 (pt 4). 821-832
6. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007 ; 73 (3). 575-586 (Pubitemid 46073952)
7. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004 ; 100 (5). 1211-1223 (Pubitemid 38541978)
8. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010 ; 105 (6). 687-701
9. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol. 2004 ; 286 (5). H1672 - H1680 (Pubitemid 38525453)
10. Mulivor AW, Lipowsky HH. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol. 2002 ; 283 (4). H1282 - H1291
11. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol. 2000 ; 279 (6). H2815 - H2823 (Pubitemid 32005870)
12. Hofmann-Kiefer KF, Kemming GI, Chappell D, et al. Serum heparan sulfate levels are elevated in endotoxemia. Eur J Med Res. 2009 ; 14 (12). 526-531
13. Jacob M, Chappell D, Hofmann-Kiefer K, Conzen P, Peter K, Rehm M.. Determinants of insensible fluid loss: Perspiration, protein shift and endothelial glycocalyx [in German]. Anaesthesist. 2007 ; 56 (8). 747-758, 760-764.
14. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 2008 ; 30 (6). 623-627
15. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008 ; 29 (5). 572-576 (Pubitemid 351544076)
16. Henrich M, Gruss M, Weigand MA. Sepsis-induced degradation of endothelial glycocalix. Scientific World Journal. 2010 ; 10: 917-923
17. Chappell D, Hofmann-Kiefer K, Jacob M, et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009 ; 104 (1). 78-89
18. Oragui EE, Nadel S, Kyd P, Levin M. Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria. Crit Care Med. 2000 ; 28 (8). 3002-3008
19. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy 1. Am J Obstet Gynecol. 1999 ; 180 (2 pt 1). 499-506 (Pubitemid 29093892)
20. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension. 2002 ; 39 (1). 155-160 (Pubitemid 34098104)
21. Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V. Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension. 2001 ; 38 (3). 394-398 (Pubitemid 34225672)
22. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009 ; 9: 8
23. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes. 2006 ; 55 (2). 480-486 (Pubitemid 43343279)
24. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 2000 ; 101 (13). 1500-1502 (Pubitemid 30180883)
25. Martin JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999 ; 180 (6 pt 1). 1373-1384 (Pubitemid 29293255)
26. O'Hara Padden M. HELLP Syndrome: recognition and perinatal management. Am Fam Physician. 1999 ; 60 (3). 829-839 (Pubitemid 29442061)
27. van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv. 2005 ; 60 (1). 57-70 (Pubitemid 40039864)
28. Smith HL. Matching with multiple controls to estimate treatment effects in observational studies. Sociol Methodol. 1997 ; 27: 325-353 (Pubitemid 127341532)
29. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM.. Customised antenatal growth charts. Lancet. 1992 ; 339 (8788). 283-287
30. Steegers EA, von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010 ; 376 (9741). 631-644
31. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007 ; 116 (17). 1896-1906 (Pubitemid 350287085)
32. Kim JM, Lee JA, Cho IS, Ihm CH. Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study. Korean J Hematol. 2010 ; 45 (2). 115-119
33. Anttonen A, Leppa S, Ruotsalainen T, Alfthan H, Mattson K, Joensuu H. Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2003 ; 41 (2). 171-177 (Pubitemid 36842780)
34. Parsian H, Rahimipour A, Nouri M, et al. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. J Gastrointestin Liver Dis. 2010 ; 19 (2). 169-174
35. Puder JJ, Blum CA, Mueller B, De GC, Dye L, Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest. 2006 ; 36 (1). 58-64
36. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online. 2006 ; 13 (5). 680-686 (Pubitemid 44760892)
37. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol. 2007 ; 39 (3). 505-528 (Pubitemid 46099032)
38. Jokimaa V, Inki P, Kujari H, Hirvonen O, Ekholm E, Anttila L. Expression of syndecan-1 in human placenta and decidua. Placenta. 1998 ; 19 (2-3). 157-163 (Pubitemid 28112199)
39. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 2000 ; 92 (1). 35-43
40. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000 ; 21 (7). 597-602
41. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998 ; 105 (6). 632-640 (Pubitemid 28293481)
42. Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006 ; 27 (1). 56-61 (Pubitemid 41662880)
43. Gotte M, Echtermeyer F. Syndecan-1 as a regulator of chemokine function. ScientificWorldJournal. 2003 ; 3: 1327-1331
44. Gotte M. Syndecans in inflammation. FASEB J. 2003 ; 17 (6). 575-591 (Pubitemid 37221142)
45. Jokimaa VI, Kujari HP, Ekholm EM, Inki PL, Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol. 2000 ; 183 (6). 1495-1498 (Pubitemid 32061214)
46. Simon AC, Levenson J, Flaud P. Pulsatile flow and oscillating wall shear stress in the brachial artery of normotensive and hypertensive subjects. Cardiovasc Res. 1990 ; 24 (2). 129-136 (Pubitemid 20069487)
47. Simon AC, Levenson J. Abnormal wall shear conditions in the brachial artery of hypertensive patients. J Hypertens. 1990 ; 8 (2). 109-114 (Pubitemid 20167762)
48. Bruegger D, Jacob M, Rehm M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol. 2005 ; 289 (5). H1993 - H1999 (Pubitemid 41507349)
49. Borghi C, Cicero AF, Degli ED, et al. Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy. Intern Emerg Med. 2011 ; 6 (3). 227-234
50. Kupferminc MJ, Peaceman AM, Wigton TR, Tamura RK, Rehnberg KA, Socol ML. Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol. 1994 ; 171 (4). 976-979 (Pubitemid 24341480)
51. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998 ; 40 (2). 102-111
52. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol. 1995 ; 102 (1). 20-25
53. Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HC. Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol. 1994 ; 101 (12). 1081-1082 (Pubitemid 24376873)
54. Schipper EJ, Bolte AC, Schalkwijk CG, Van Geijn HP, Dekker GA. TNF-receptor levels in preeclampsia - results of a longitudinal study in high-risk women. J Matern Fetal Neonatal Med. 2005 ; 18 (5). 283-287 (Pubitemid 43062374)
55. van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy. 2008 ; 27 (3). 253-265
56. Sibai B, Romero R, Klebanoff MA, et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol. 2009 ; 200 (6). e1 - e8
57. Fantuzzi G, Demitri MT, Ghezzi P. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Clin Exp Immunol. 1994 ; 96 (1). 166-169 (Pubitemid 24213815)
58. Reikeras O, Helle A, Krohn CD, Brox JI. Effects of high-dose corticosteroids on post-traumatic inflammatory mediators. Inflamm Res. 2009 ; 58 (12). 891-897
59. Man SF, Xuekui Z, Vessey R, et al. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Ther Adv Respir Dis. 2009 ; 3 (2). 73-80
60. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000 ; 183 (1). S1 - S22